PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Literature Review

Volume 4 Issue 4

Antimicrobial Potential of Herbal Products Against Clostridioides difficile

Anesa Jerkovic-Mujkic*, Kerima Masic and Tvrtko-Jasmin Dzelilovic

March 28, 2024

DOI : 10.56831/PSMPH-04-136

View PDF

Abstract

Clostridioides difficile infection (CDI) is a major cause of hospital-acquired diarrhea, with significant morbidity and mortality. In the past decade, the incidence rates of community-acquired CDI are increasing worldwide. Antibiotic therapy which alters the normal colonic microbiota is the greatest risk factor for the development of these infections. The number of effective antibiotics for the treatment of CDI is limited, so it is necessary to explore alternative approaches in therapy. One of the approaches to solving this medical and public health problem is the use of plants and their products.

The aim of the present work is to explore the antimicrobial activity of herbal products against C. difficile in order to point out which herbal products are the most promising for the treatment and prevention of CDI.

We searched JSTOR, PubMed, ScienceDirect, Scopus, Springer Link and Web of Science databases for articles identifying herbal products targets or antimicrobial treatments for C. difficile. While searching certain keywords were used to find the publications that would be relevant in this review.

The study indicates that several essential oils, plant extracts, and their pure compounds exhibit a great antimicrobial potential against C. difficile, suggesting their possible use as an alternative to antibiotics or in combination with conventional antibiotics for the treatment of CDI.

Keywords: essential oils; plant extracts; pure component; Clostridioides difficile; antimicrobial activity

References

  1. Huemer M., et al. "Antibiotic resistance and persistence - Implications for human health and treatment perspectives". EMBO reports (2020): e51034.
  2. Ventola CL. "The Antibiotic Resistance Crisis Part 1: Causes and Threats". Pharmacy and Therapeutics (2015): 277-283.
  3. Larsson DGJ and Flach C-F. "Antibiotic resistance in the environment". Nature Reviews Microbiology (2021): 257-269.
  4. Lerminiaux NA and Cameron ADS. "Horizontal transfer of antibiotic resistance genes in clinical environments". Canadian Journal of Microbiology (2019): 34-44.
  5. Lawson PA., et al. "Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938". Anaerobe (2016): 95-99.
  6. Czepiel J., et al. "Clostridium difficile infection: review". European Journal of Clinical Microbiology & Infectious Diseases (2019): 1211-1221.
  7. Kordus SL, Thomas AK and Lacy DB. "Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics". Nature Reviews Microbiology (2022): 285-298.
  8. Qassadi FI, Zhu Z and Monaghan TM. "Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria". Pathogens (2023): 333.
  9. Burki TK. "Superbugs: An Arms Race Against Bacteria". The Lancet Respiratory Medicine (2018): 668.
  10. Janvilisri T., et al. "Alternative Therapeutic Approaches For Multidrug Resistant Clostridium difficile". Frontiers in Microbiology (2019): 1216.
  11. Page MJ., et al. "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews". thebmj (2021): 372.
  12. Sarkis-Onofre R., et al. "How to properly use the PRISMA Statement". Systematic Reviews (2021): 117.
  13. Martínez-Alva JE., et al. "In vitro analysis of extracts of plant used in Mexican traditional medicine, which are useful to combat Clostridioides difficile infection". Pathogens (2022): 774.
  14. Roshan N., et al. "Natural products show diverse mechanisms of action against Clostridium difficile". Journal of Applied Microbiology (2019): 468-479.
  15. Roshan N, Riley TV and Hammer K. "Antimicrobial activity of natural products against Clostridium difficile in vitro". Journal of Applied Microbiology (2017): 92-103.
  16. Aleksić A., et al. "In vitro anti-clostridial action and potential of the spice herbs essential oils to prevent biofilm formation of hypervirulent Clostridioides difficile strains isolated from hospitalized patients with DCI". Anaerobe (2022): 102604.
  17. Tosun MN, Taylan G and Demirel Zorba NN. "Antibacterial and antibiofilm activities of some plant essential oils and synergistic effects of cinnamon essential oil with vancomycin against Clostridioides difficile: In vitro study". Letters in Applied Microbiology (2022): 598-606.
  18. Fraternale D, Genovese S and Ricci D. "Essential oil composition and antimicrobial of aerial parts and ripe fruits of Echinophora spinosa (Apiaceae) from Italy". Natural product Communications (2013): 527-530.
  19. Fraternale D, Flamini G and Ricci D. "Essential Oil Composition and Antimicrobial Activity of Angelica archangelica L. (Apiaceae) Roots". Journal of Medicinal Food (2014): 1043-1047.
  20. Gadhi CA., et al. "Antibacterial activity of Aristolochia paucinervis Pomel". Journal of Ethnopharmacology (1999): 87-92.
  21. Perumalsamy H., et al. "Growth-Inhibiting and morphostructural effects of constituents identified in Asarum heterotropoides root on human intestinal bacteria". BMC Complementary Medicine and Therapies (2013): 245.
  22. Canning C., et al. "Antibacterial and cytotoxic activity of isoprenylated coumarin mammea A/AA isolated from Mammea africana". Journal of Ethnopharmacology (2013): 259-262.
  23. Spengler G., et al. “Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. spp. macrocarpa Aerial parts". Microorganisms (2022): 758.
  24. Liu X-W., et al. "Isobavachalcone from Cullen corylifolium Presents Significant Antibacterial Activity Against Clostridium difficile Through Disruption of the Cell Membrane". Frontiers in Pharmacology (2022): 914188.
  25. Sukumar MR and König B. "Pomegranate extract specifically inhibits Clostridium difficile growth and toxin production without disturbing the beneficial bacteria in vitro". Infection and Drug Resistance (2018): 2357-2362.
  26. Finegold SM., et al. "Pomegranate Extract Exhibits in Vitro Activity Against Clostridium difficile". Nutrition (2014): 1210-1212.
  27. Justin S and Antony B. "Antibacterial activity of the essential oils of Syzygium aromaticum (L.) Merr. Perry (Clove), Myristica fragrans Houtt. (Nutmeg) and Zingiber officinale Roscoe (Ginger) against clinical isolates of Clostridium difficile: An in vitro study". International Journal of Contemporary Medical Research (2016): 1085-1089.
  28. de Nova PJG., et al. "In vitro Susceptibility and Evaluation of Techniques for understanding the Mode of Action of a Promising Non-antibiotic Citrus Fruit Extract Against Several Pathogens". Frontiers in Microbiology (2019): 884.
  29. Aljarallah KM. "Inhibition of Clostridium difficile by natural herbal extracts". Journal of Taibah University Medical Sciences (2016): 427-431.
  30. Roshan N., et al. "Effect of natural products on the production and activity of Clostridium difficile toxins in vitro". Nature Scientific Reports (2018): 1-9.
  31. Roshan N, Riley TV and Hammer KA. "Effects of natural products on several stages of the spore cycle of Clostridium difficile in vitro". Journal of Applied Microbiology (2018): 710-723.
  32. Haro-González JN., et al. "Clove Essential Oil (Syzygium aromaticum L. Myrtaceae): Extraction, Chemical Composition, Food Applications, and Essential Bioactivity for Human Health". Molecules (2021): 6387.
  33. Warsito MF. "A Review on Chemical Composition, Bioactivity, and Toxicity of Myristica fragrans Houtt. Essential Oil". Indonesian Journal of Pharmacy (2021): 304-313.
  34. Mahboubi M. "Zingiber officinale Rosc. essential oil, a review on its composition and bioactivity". Clinical Phytoscience (2019): 1-12.
  35. Aleem M., et al. "Botany, phytochemistry and antimicrobial activity of ginger (Zingiber officinale): A review". International Journal of Herbal Medicine (2020): 36-49.
  36. Beristain-Bauza SDC., et al. "Antimicrobial Activity of Ginger (Zingiber officinale) and Its Application in Food Products". Food Reviews International (2019): 407-426.
  37. Thapa D., et al. "Sensitivity of pathogenic and commensal bacteria from the human colon to essential oils". Microbiology (2012): 2870-2877.
  38. Thapa D., et al. "Essential oils have different effects on human pathogenic and commensal bacteria in mixed fecal fermentations compared with pure cultures". Microbiology (2015): 441-449.
  39. Blaskovich MAT., et al. "The antimicrobial potential of cannabidiol". Communications Biology (2021): 7.
  40. Harnvoravongchai P., et al. "Antimicrobial Effect of Asiatic Acid Against Clostridium difficile Is Associated With Disruption of Membrane Permeability". Frontiers in Microbiology (2018): 2125.
  41. Mody D, Athamneh AIM and Seleem MN. "Curcumin: A natural derivative with antibacterial activity against Clostridium difficile". Journal of Global Antimicrobial Resistance (2020): 154-161.
  42. Cermak P., et al. "Strong antimicrobial activity of xanthohumol and other derivatives from hops (Humulus lupulus L.) on gut anaerobic bacteria". APMIS (2017): 1033-1038.
  43. Sleha R., et al. "Strong antimicrobial effects of xanthohumol and beta-acids from hops against Clostridioides difficile infection in vivo". Antibiotics (Basel) (2021): 392.
  44. Doyle AA and Stephens JC. "A review of cinnamaldehyde and its derivatives as antibacterial agents". Fitoterapia (2019): 104405.
  45. Mooyottu S., et al. "Carvacrol and trans-cinnamaldehyde reduce Clostridium difficile toxin production and cytotoxicity in vitro". International Journal of Molecular Sciences (2014): 4415-4430.
  46. Mooyottu S, Flock G and Venkitanarayanan K. "Carvacrol reduces Clostridium difficile sporulation and spore outgrowth in vitro". Journal of Medical Microbiology (2017): 1229-1234.
  47. Pellissery JA, Vinayamohan GP and Venkitanarayanan K. "In vitro antivirulence activity of baicalin against Clostridioides difficile". Journal of Medical Microbiology (2020): 631-639.
  48. Chen J-C., et al. "Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice". Journal of Agriculture and Food Chemistry (2007): 8390-8397.
  49. Rozza AL., et al. "Effect of menthol in experimentally induced ulcers: Pathways of gastroprotection". Chemico-Biological Interactions (2013): 272-278.
  50. Shilling M., et al. "Antimicrobial effects of virgin coconut oil and its medium-chain fatty acids on Clostridium difficile". Journal of Medical Food (2013): 1079-1085.
  51. Yang H-T., et al. "Lauric Acid is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model". Frontiers in Microbiology (2018): 2635.
  52. Matsue M., et al. "Measuring the Antimicrobial Activity of Lauric Acid against Various Bacteria in Human Gut Microbiota Using a New Method". Cell Transplantation (2019): 1528-1541.
  53. Qassadi FI, Zhu Z and Monaghan TM. "Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria". Pathogens (2023): 333.
  54. Wang S., et al. "Uptake and levels of the antibiotic berberine in individual dormant and germinating Clostridium difficile and Bacillus cereus spores as measured by laser tweezers Raman spectroscopy". Journal of Antimicrobial Chemotherapy (2016): 1540-1546.
  55. Wultańska D, Piotrowski M and Pituch H. "The effect of berberine chloride and/or its combination with vancomycin on the growth, biofilm formation, and motility of Clostridioides difficile". European Journal of Clinical Microbiology & Infectious Diseases (2020): 1391-1399.
  56. Domadia PN., et al. "Berberine targets assembly of Escherichia coli cell division protein FtsZ". Biochemistry (2008): 3225-3234.
  57. Boberek JM, Stach J and Good L. "Genetic Evidence for Inhibition of Bacterial Division Protein FtsZ by Berberine". PLoS One (2010): e13745.
  58. Sun N., et al. "Rational Design of Berberine-Based FtsZ Inhibitors with Broad-Spectrum Antibacterial Activity". PLoS One (2014): e97514.
  59. Leontiev R., et al. "A Comparison of the Antibacterial and Antifungal Activities of Thiosulfinate Analogues of Allicin". Scientific Reports (2018): 6763.
  60. Farha AK., et al. "Tannins as an alternative to antibiotics". Food Bioscience (2020): 100751.
  61. Lv Z., et al. "Berberine Blocks the Relapse of Clostridium difficile Infection in C57BL/6 Mice after Standard Vancomycin Treatment". Antimicrobial Agents and Chemotherapy (2015): 3726-3735.
  62. Tortajada-Girbés M., et al. "Alimentary and Pharmaceutical Approach to Natural Antimicrobials against Clostridioides difficile Gastrointestinal Infection". Foods (2021): 1124.